Akeso and Summit have announced significant results from their clinical trials involving the bispecific antibody, ivonescimab, which targets both PD-1 and VEGF pathways. The study demonstrated...
Recent findings from the phase 3 VIKTORIA-1 trial indicate that the combination of the PI3K/AKT/mTOR inhibitor gedatolisib and fulvestrant (Faslodex), with or without palbociclib (Ibrance), significantly...
A recent change in insurance policy has raised concerns among cancer patients, with many feeling inadequately supported in their treatment journeys. Specifically, patients like Robin, a...
A new study has identified a significant correlation between regular soft drink consumption and an increased risk of depression, particularly among women. The research indicates that...
In March 2021, a 4-year-old girl named Sakura Tafoya experienced a frightening health crisis while playing soccer in Santa Fe, New Mexico. After attempting a move...
A significant number of users have reported a dramatic decrease in hair fall after using the Svvimer Rice Water Hair Growth Shampoo, priced at just $20....
The latest findings from the phase 3 DESTINY-Breast05 trial reveal that treatment with **fam-trastuzumab deruxtecan-nxki** (T-DXd; Enhertu) significantly improves invasive disease-free survival (IDFS) compared to **ado-trastuzumab...
A recent phase 2 clinical trial has revealed that the combination of BNT111 and cemiplimab (Libtayo) demonstrated a notable objective response rate (ORR) of 18.1% in...
In a significant advancement for cancer treatment, the combination of Padcev (enfortumab vedotin) and Keytruda (pembrolizumab) has demonstrated improved survival rates in patients with locally advanced...
Dozens of health professionals and care providers at Kaiser Permanente in Longview, Washington, joined a nationwide strike on October 4, 2023. This action was part of...
